204 related articles for article (PubMed ID: 36530029)
1. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
Li W; Jiang Y; Pan Q; Yang G
Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
[TBL] [Abstract][Full Text] [Related]
2. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
4. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3.
Wang X; Wei P; Yang L; Liu F; Tong X; Yang X; Su L
Chin Med J (Engl); 2022 Sep; 135(17):2089-2097. PubMed ID: 35143426
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
7. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
[TBL] [Abstract][Full Text] [Related]
8. LINC01291 promotes hepatocellular carcinoma development by targeting the miR-186-5p/OXSR1 axis.
Chu J; Geng G; Ai X; Jia W; Wang J; Xu B; Kong X; Kong L
J Gene Med; 2022 Feb; 24(2):e3394. PubMed ID: 34665488
[TBL] [Abstract][Full Text] [Related]
9. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.
Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J
Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376
[TBL] [Abstract][Full Text] [Related]
10. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p.
Chen PP; Zhang ZS; Wu JC; Zheng JF; Lin F
Cell Signal; 2021 Aug; 84():109992. PubMed ID: 33774129
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
Liang Z; Li X; Duan F; Song L; Wang Z; Li X; Yang P; Li L
Hum Cell; 2022 Jan; 35(1):299-309. PubMed ID: 34784010
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.
Ding B; Lou W; Fan W; Pan J
Environ Toxicol; 2023 May; 38(5):1038-1052. PubMed ID: 36722453
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anti-metastatic effect of the alkaliod matrine from Sophora flavecens on hepatocellular carcinoma and its mechanisms.
Dai M; Chen N; Li J; Tan L; Li X; Wen J; Lei L; Guo D
Phytomedicine; 2021 Jul; 87():153580. PubMed ID: 34029939
[TBL] [Abstract][Full Text] [Related]
16. miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.
Liu HT; Luo CP; Jiang MJ; Deng ZJ; Teng YX; Su JY; Pan LX; Ma L; Guo PP; Zhong JH
Clin Transl Oncol; 2023 Oct; 25(10):2960-2971. PubMed ID: 37024636
[TBL] [Abstract][Full Text] [Related]
17. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.
Zhang H; Wang Y; Ding H
Clin Transl Oncol; 2021 Oct; 23(10):2078-2089. PubMed ID: 33891266
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA TTN antisense RNA 1 facilitates hepatocellular carcinoma progression via regulating miR-139-5p/SPOCK1 axis.
Zhu X; Jiang S; Wu Z; Liu T; Zhang W; Wu L; Xu L; Shao M
Bioengineered; 2021 Dec; 12(1):578-588. PubMed ID: 33517826
[TBL] [Abstract][Full Text] [Related]
19. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1.
Jiang SP; Li ZR
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2028-2037. PubMed ID: 30915746
[TBL] [Abstract][Full Text] [Related]
20. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]